Baxter (BAX) stock jumps as the company exceeds Street forecasts with its Q1 2026 financials thanks to international sales.

Baxter International Inc. BAX reported better-than-expected first-quarter earnings on Thursday and reaffirmed its fiscal 2026 ...

By Kamal Choudhury April 30 (Reuters) - Baxter on Thursday stuck to its annual forecast after it beat Wall Street estimates for first-quarter results, and said it is closely monitoring the conflict in ...

April 30 (Reuters) - Baxter on Thursday beat Wall Street estimates for first-quarter profit and revenue, helped by robust sales in its medical products and therapies unit. Shares of the ...

Baxter President and CEO Andrew Hider's total compensation for 2025 makes him one of the highest paid CEOs in medtech.

Baxter International Inc. (BAX) on Thursday reported a first-quarter loss of $15 million, after reporting a profit in the same period a year earlier.

Baxter (NYSE:BAX) today reported first-quarter results that came in ahead of the consensus forecast on Wall Street.

Baxter (BAX) delivered earnings and revenue surprises of +15.42% and +3.74%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?